Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Karagiannis T, Avgerinos I, Liakos A, et al
-
What about this customer review
Clinicians should recognize these agents as an important and underutilized tool when caring for this high-risk population. Luciana Veroza Viana, PhD, post-graduate program, Medical Sciences, Endocrinology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil Looking ahead, the team is planning a long-term review of metabolic complications among their outpatient population with schizophrenia over the past two decades, a project led by Professor of Psychiatry Clarissa Gama and her student Luiza Sperb that aims to identify key factors associated with increased metabolic risk
GLP-1 receptor agonists are primarily used to manage Type 2 diabetes and promote weight loss in individuals with obesity
In a model of high-fat diet/streptozotocin-induced diabetic rats, Saxagliptin (1 mg/kg for 12 weeks) notably improves pancreatic insulin secretion and increased the -cell to -cell ratio
US$ 25.01
US$ 25.38
US$ 26.17
US$ 29.50
US$ 25.74
